Applying Dry Powder Coatings - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Applying Dry Powder Coatings
The authors experiment with a resonant acoustic mixer as a method for dry powder coating.

Pharmaceutical Technology
Volume 35, Issue 10, pp. 94-102

Materials and methods

A selection of pharmaceutical powders were chosen as host particles with different particle sizes, particle shapes, and chemistry: ibuprofen (50 grade and 90 grade, BASF), acetaminophen (micronized, Mallinckrodt Baker), proprietary active pharmaceutical ingredients (API "A" and API "B," Pfizer), mannitol (powder grade, SPI Pharma), and lactose monohydrate (310 grade, Foremost Farms). Four guest particles were selected and represented a range of small microsized or nanosized particles commonly used as glidants or lubricants in solid dosage formulations: hydrophobic silicon dioxide (Aerosil R972, Evonik/Degussa), hydrophilic silicon dioxide (Aerosil 200, Evonik/Degussa), titanium dioxide (USP grade, Brenntag Specialties), and magnesium stearate (HyQual, Mallinckrodt Baker).

RAM dry powder coating. A resonant acoustic mixer (LabRAM, 500 g capacity, Resodyn) was used to prepare the coated particles in small batches (~20 g). The host and guest particles were placed into amber glass bottles and mixed for as much as 10 min at a frequency of 60–61 Hz and a mechanical driver magnitude of 75–80 times the acceleration of gravity. The mixing oscillation mixing frequency was optimized by the RAM driver control module to mix the powder at resonance.

Comil dry powder coating. An overdriven comil (model 197, Quadro Engineering) was also used to prepare dry-coated particles. Details of this approach for coating were previously reported (1). This process required the selection of comil operating conditions (i.e., screens, impeller, operating speed, and the powder feeding rate) to maximize dispersion of the guest particles and enable throughput without screen blinding. A round-edged impeller rotating at a tip speed of 2.4 m/s and round hole screens (0.457 to 0.813 mm opening) were selected to maximize residence time and minimize host-particle attrition. The screen opening size was slightly above the maximum particle size of the host particle and the powder was manually charged to the mill at 10–200 g/min.

Powder characterization. Photomicrographs were taken with a scanning electron microscope (FEI Quanta 200, FEI) using a working distance of 10 mm with an accelerating voltage of 5 kV. The particle-size distribution was determined using a laser-diffraction particle-size analyzer (Sympatec HELOS/RODOS, Sympatec) with dry dispersion capability. The bulk density was determined using the USP <616> method. The flow behavior of powders equilibrated at 50% relative humidity was determined using an annular shear cell (Schulze Ring Shear Tester model RST-XS, Wolfenbüttel, Germany) using a preconsolidation stress of 4 kPa. The ratio of the principal consolidation stress to the unconfined yield strength was used to calculate the flow function coefficient (FFC). The FFC was used as an indicator of powder flow performance. Powders with FFC values between 4 and 10 were considered easy flowing, and higher FFC values indicate superior flow behavior (9).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here